SMA is a genetic condition that impacts motor neurons, leading to muscle weakness that affects essential functions like breathing and movement. Treatments like Spinraza and Zolgensma can help manage ...

Spinal muscular atrophy (SMA) is a genetic neuromuscular condition caused by mutations in the SMN1 gene. SMA is characterized by symmetrical progressive (proximal predominant) muscle atrophy caused by ...

Spinal muscular atrophy (SMA) is a rare genetic condition that impairs a person’s ability to control their muscle movement. Most types of SMA are diagnosed in infants, but the condition sometimes ...

Authors of a systematic literature review concluded more research is needed to better understand the financial burden of spinal muscular atrophy (SMA). More robust, long-term studies are needed to ...

As the feasibility of phase 1 clinical trials for prenatal spinal muscular atrophy (SMA) therapies is explored, patient and parent input on prenatal testing and possibly treatment is a valuable tool ...

Spinal muscular atrophy (SMA) is a rare genetic disorder that causes severe muscle weakness. SMA usually affects children, and is typically diagnosed in the first 18 months of life. In its most ...